KR20200025756A - Apparatus and method for providing customized medication information to patednts based on big data - Google Patents

Abstract

Disclosed in the present disclosure is a method for generating and providing patient-specific medication information. In particular, the method can provide optimal medication information for a patient by using drug information prescribed for the patient, personal identification information of the patient, current health status information, and surrounding environment information, and further, reliable medication information can be provided by effectively regenerating and providing medication information through periodic question-and-answer with the patient.

Description

Apparatus for providing customized medication information based on big data and method for providing medication information {APPARATUS AND METHOD FOR PROVIDING CUSTOMIZED MEDICATION INFORMATION TO PATEDNTS BASED ON BIG DATA}

The present disclosure generates a customized medication information using the user identification information, surrounding environment information, current user status information, and the like, to provide the user device with the medication information, thereby enabling the user to form an accurate and effective medication habit. A providing apparatus and method are disclosed.

As the current division of labor system is implemented, specialty medicines are only prepared by doctor's prescription. However, it is difficult for a pharmacist to always know exactly all the information about various prescription drugs, and there is a problem in that accurate medication information cannot be delivered to the patient because personal information, eating habits, etc. are different for each patient.

In addition, in the case of general medicines as well as specialty medicines, information related to medicines due to the development of science and technology is increasing as many large pharmaceutical companies constantly develop and market new drugs. In addition, with the development of science, the possibility of developing and marketing a new drug that can provide a different effect from the past is gradually increasing, and thus, medication guidance information on drugs that the pharmacist should be aware of is further increased.

Despite the necessity of accurate medication guidance for various medicines, it was necessary to provide medication guidance based on the knowledge or memory of the pharmacist in the past, and medication guidance, such as simply specifying the time and number of medicines, was effectively delivered to the patient. It was hard to be.

In such cases, incorrect medications may lead to wrong medication guidance or omission of medication guidance, which may result in medication side effects in patients who do not have accurate information on medicines that have a significant effect on the body. There was a risk.

In addition, even if the patient received accurate medication information from the pharmacist, there is a high possibility of forgetting the contents, and if the information written on the medication information is lost, it is difficult to obtain the medication information again.

Therefore, there is an increasing demand for a technology that can provide accurate and effective customized medication information by sensing current environment information along with personal identification information such as patient's personal propensity information, current status information and accumulated medication information. .

Patent Publication No. 10-2004-0040842

According to an embodiment of the present disclosure, identification information such as accumulated medication information of the user, physical information of the user, health state information, and the like are generated, and patient-specific medication information is generated using artificial intelligence based on the acquired information, An apparatus and method for effectively delivering medication information through continuous communication with a device are provided.

According to the first embodiment, using the identification information of the user, it may be provided to obtain the medication history information of the user from an external server.

The method may include obtaining medicine information prescribed by a user from a medicine prescription related document provided by the user.

And obtaining current state information such as a user's body temperature, heart rate, a user's blood pressure, and blood sugar information from a user device located in proximity to the user. According to an embodiment, the user device may mean a user terminal worn by or held by the user. Therefore, the medication information providing apparatus may provide a step of acquiring the current state information of the user's body temperature, heart rate, the user's blood pressure, blood sugar information, etc. from the user terminal worn or held by the user.

Here, the degree of proximity to the user may vary depending on the performance of at least one sensor included in the user device. In particular, the proximity of the user means that the sensors are located within an area where the user's state can be checked.

According to another embodiment, the user device possessed by the user may receive the user's state information from another wearable device or other device worn by the user through communication and provide the same to the server.

Using AI first learning model, based on the user's medication history information, medicine information, the user's current status information and the surrounding environment information, the medication information, precautions, side effects, and proper intake of the medicine appropriate to the current status of the user The method may include generating first user-customized medication information including at least one of a frequency and an appropriate intake time of the medicine.

Providing user-specific medication information to the user device may be provided.

Using the artificial intelligence second learning model, generating question information related to user-specific medication information and providing the generated question information to the user device may be provided.

And receiving answer information about the question information from the user device.

Modifying the first user-specific medication information based on the answer information, and providing the second user-specific medication information according to the state of the user who is taking the medication.

In addition, according to another disclosure, a computer program product including a computer readable storage medium may be provided.

By using the accumulated medication related information and the current state information of the patient, it is possible to create a user-specific medication information, and can be provided by modifying the medication information according to the user's state by using the question and answer information with the patient device, It is advantageous to generate customized user medication information.

In addition, by using artificial intelligence data to provide the precautions, such as side effects that may occur in the drug included in the patient's prescription to match the patient's condition, the patient can obtain the medication information according to the current state of the patient have.

It is possible to easily collect the unrecognized effects or side effects of medicines by obtaining information on unknown improvement effects, side effects, other effects than prescriptions, etc. Can be used to help develop new drugs.

1 is a view schematically illustrating an embodiment in which a medication information providing apparatus according to one disclosure provides medication information to a user device.
2A is a diagram illustrating types of a user device for detecting a current state of a user, according to an exemplary embodiment.
2B is a diagram illustrating a wearable device that measures a current state of a user and provides state information of the user to a medication information providing device.
3 is a view for explaining an embodiment of informing the medication information to the user's device according to one disclosure.
4 is a diagram illustrating a device screen for obtaining user information for providing medication information according to one disclosure.
FIG. 5 is a diagram illustrating an embodiment of regenerating and providing medication information when an answer to a question related to medication information is received from a user device according to one disclosure.
6 is a diagram illustrating a configuration of a medication information providing apparatus according to one disclosure.
7 is a block diagram illustrating a detailed configuration of an apparatus for providing medication information according to one disclosure.
8 is an exemplary diagram of an I-Shape Extended Curvature Gabor Classifier Bunch group.
9 is a flowchart illustrating a method for authenticating a user while maintaining privacy between members using a blockchain according to one disclosure.
10 is a diagram illustrating an example of information stored in a blockchain for user identification and authentication according to an embodiment of the present invention.
FIG. 11 is a diagram for explaining technical features of sharing medication information using a blockchain network according to one disclosure.
12 is a view for explaining an embodiment related to non-contact sensing according to one disclosure.

DETAILED DESCRIPTION Hereinafter, exemplary embodiments of the present invention will be described in detail with reference to the accompanying drawings so that those skilled in the art may easily implement the present invention. As those skilled in the art would realize, the described embodiments may be modified in various different ways, all without departing from the spirit or scope of the present invention. In the drawings, parts irrelevant to the description are omitted in order to clearly describe the present invention, and like reference numerals designate like parts throughout the specification.

Throughout the specification, when a part is "connected" to another part, it includes not only "directly connected" but also "electrically connected" with another element in between. . In addition, when a part is said to "include" a certain component, this means that it may further include other components, except to exclude other components unless otherwise stated.

Hereinafter, the user refers to a patient who is an insurance subscriber, and the user may claim the insurance using the medication information providing apparatus, and may be the user himself or a third party such as a family claiming the insurance on behalf of the user. Hereinafter, the patient claiming the insurance, the user of the pharmacy will be described as a user.

Hereinafter, the present invention will be described in detail with reference to the accompanying drawings.

1 is a view schematically illustrating an embodiment in which a medication information providing apparatus according to one disclosure provides medication information to a user device.

The medication information providing apparatus 200 is preferably a management server, but is not limited thereto and may be a medication information providing terminal in the form of a kiosk disposed in a pharmacy or a hospital. In the case of using a chip capable of machine learning in the terminal, the method of the present invention can also be implemented in the medication information providing terminal.

According to one disclosure, the medication information providing apparatus 200 may be any one of a kiosk, a server, a portable device, and a computer device, and is not limited in form. In addition, in FIG. 1, a process of receiving a plurality of pieces of information and generating medication information and delivering the medication information to a user device is described using a plurality of devices. However, the present invention is not limited thereto.

For example, the medication information providing apparatus 200 may be a mobile phone, a smart phone, a laptop computer, a tablet PC, an e-book device, a digital broadcasting terminal, a personal digital assistant (PDA), a portable multimedia (PMP). Player), navigation, MP3 player, digital camera, glasses, wrist watch, etc. can be implemented as a wearable device (wearable device), such as in this case, receiving the biometric information of the user in real time and at the same time through the artificial intelligence learning medication information Can be generated.

According to another embodiment, when the medication information providing apparatus 200 is implemented as a server, the server may be located close to the user or remotely. In this case, the medication information providing apparatus 200 may receive information on sensing a user's biosignal from a device located close to the user, or may receive information about the surrounding environment, and may be used at a kiosk, a health related website, or another hospital server. Receiving information on the treatment history of the, it can generate the medication information by learning the received information through artificial intelligence learning. According to one disclosure, the medication information providing apparatus 200 may generate medication information and transmit the medication information to a kiosk, a user device, an external device, a hospital server, or a server of a public institution, and at this time, the external devices may be connected to a local / distance network. Communication can be performed through a communication connection or a connection through a blockchain, and the communication method is not limited.

As described above, it is obvious that the procedure of generating the medication information described in the present invention is not limited by the physical device. In addition, the method for generating medication information herein may be implemented in the form of program instructions that can be executed by various computer means and recorded in a computer readable medium. The computer readable medium may include program instructions, data files, data structures, and the like, alone or in combination. Program instructions recorded on the media may be those specially designed and constructed for the purposes of the present invention, or they may be of the kind well-known and available to those having skill in the computer software arts. Examples of computer readable recording media include magnetic media such as hard disks, floppy disks and magnetic tape, optical media such as CD-ROMs, DVDs, and magnetic disks such as floppy disks. Magneto-optical media, and hardware devices specifically configured to store and execute program instructions, such as ROM, RAM, flash memory, and the like. Examples of program instructions include not only machine code generated by a compiler, but also high-level language code that can be executed by a computer using an interpreter or the like.

According to one disclosure, the medication information providing apparatus may provide a step of obtaining medication history information of the user from a server by using the identification information of the user.

According to one disclosure, the medication information providing apparatus may provide a step of obtaining medicine information prescribed by a user from a medicine prescription related document provided by the user.

According to one disclosure, the medication information providing apparatus may provide a step of obtaining current state information of the user's body temperature, heart rate, blood pressure of the user, blood sugar information, and the like from a user device located in proximity to the user.

According to one disclosure, the medication information providing apparatus uses the artificial intelligence first learning model, based on the medication history information of the user, medicine information, the current state information of the user, and the surrounding environment information, the medication information suitable for the current state of the user. And generating first user-specific medication information including the precautions, side effects, the proper number of times of taking the medicine, and the timing of the proper intake of the medicine.

According to one disclosure, the medication information providing apparatus may provide a step of providing user-specific medication information to the user device.

According to one disclosure, the medication information providing apparatus may provide a step of generating question information related to user-specific medication information using the artificial intelligence second learning model and providing the generated question information to the user device.

According to one disclosure, the medication information providing apparatus may provide receiving answer information on question information from a user device.

According to one disclosure, the medication information providing apparatus may provide a step of modifying the first customized medication information based on the answer information to provide the second customized medication information according to the state of the user who is taking the medication. Therefore, there is an advantage that can provide user-specific medication information in real time.

According to one disclosure, the medication information providing apparatus may provide a step of acquiring surrounding environment information including temperature, humidity, fine dust concentration, weather information, etc. around a location where a current user is located from a user device or a server.

According to one disclosure, the medication information providing apparatus may provide a step of modifying the first user-specific medication information so that the effect according to the user's medicine consumption is maximized based on the surrounding environment information.

According to one disclosure, the medication information providing apparatus may provide providing the modified first user-specific medication information to the user device.

According to one disclosure, the medication information providing apparatus is based on drug identification information, disease name information, diagnosis name information, medical history information, medical treatment history information, information on the prescribed medicine, the user's physical characteristics related to the medicine information prescribed by the user The AI first learning model may be acquired based on the result of learning the medicine medication information generated based on the medical treatment information, and the medicine medication information to be provided to the user may be generated using the acquired AI first learning model. have.

At this time, the first learning model is the current state information of the user. By setting a weight on at least one of the genetic characteristic information of the user and the surrounding environment information, the time-based medicine medication information according to the current state information of the user may be generated.

For example, the first learning model may set a weight to at least one of the current state information of the user, the genetic characteristic information of the user, and the surrounding environment information according to the request of the user. For example, when receiving a request from the user device to generate a new medicine medication information together with the information that the user's current blood pressure has risen, the first learning model weights the blood pressure rise information among the current state information of the user. New drug medication information can be generated. In this case, the first learning model is an artificial intelligence learning model that takes medicines based on big data in consideration of patient status information, risk information according to blood pressure rise, blood pressure rising factor according to environmental information, and environmental information due to genetic factors. Information can be generated.

According to one disclosure, the first learning model may generate drug medication information by setting weights differently according to each information. For example, the first learning model may generate medicine medication information by concentrating on the current state information of the user by applying a weight of 0.7 to the current state information of the user and applying a weight of 0.3 to the surrounding environment information. In this case, how much weight to which information is applied and how much weight to be applied may be based on a user's selection or automatically set by artificial intelligence.

According to one disclosure, the medication information providing apparatus obtains, from a user device, health state information including at least one of a user's psychological state, drinking state, pain status, meal information, allergy information, family history information, and sleep state information. You can provide a step.

According to one disclosure, the medication information providing apparatus generates question information related to user-specific medication information by using an artificial intelligence second learning model that has learned medication information suitable for a situation-specific condition using health state information. Can provide.

For example, when there is hair loss in the family history of the user, question information about whether the hair loss effect occurs, improves, or newly occurs according to the medication effect may be generated.

According to one disclosure, the medication information providing apparatus may provide a step of regenerating user-specific medication information based on answer information periodically obtained from a user device.

For example, if hair loss has been answered, information may be generated and provided, including information on whether to reduce or stop taking the medicine.

According to one disclosure, the medication information providing apparatus may provide a step of encrypting the first user-specific medication information and the second user-specific medication information using a blockchain.

According to one disclosure, the medication information providing apparatus may provide storing the encrypted first user customized medication information and the second user customized medication information to be provided to at least one device authenticated through the blockchain.

According to one disclosure, the at least one device may include a server of a hospital server, a pharmaceutical company server, a drug supply company, and the like, but is not limited thereto.

For better understanding, reference is made to FIG. 10.

10 is a diagram illustrating an example of information stored in a blockchain for user identification and authentication according to an embodiment of the present invention.

Referring to FIG. 10, the medication information providing apparatus stores and manages at least one of a personal information agreement, an authentication code, and an access token on a blockchain in order to perform authentication of at least one user device according to a standard protocol such as Oauth. .

The medication information providing apparatus stores a pair of authentication information (eg, a user ID) and data in the IN area and the OUT area of the block 200 of the blockchain. The medication information providing apparatus generates authentication information in various forms to easily store, manage, and retrieve information such as a user authentication code and an access code necessary for access to a drug company, a hospital, and the like.

First, the medication information providing apparatus generates the first authentication information based on the user identification information. The medication information providing apparatus may generate, as the first authentication information, a hash value calculated by using the user identification information as an input of a hash function. The medication information providing apparatus stores the first authentication information in the IN area of the block, and stores the medicine prescription information, user identification information, and personal information consent in the OUT area of the same block.

According to one disclosure, the user identification information may include biometric information of the user. For example, the user identification information may include a user's fingerprint, voice, facial recognition, iris recognition, and the like, without limiting the biometric information.

By one disclosure, the parameter values (temperature, humidity, fine dust, etc.) applied to the AI learning and prediction may be stored in the blockchain network.

The medication information providing apparatus generates second authentication information based on the first random number value. The medication information providing apparatus may generate the first random number value as the second authentication information as it is or generate a hash value for the first random number value as the second authentication information. The second authentication information is used as an authentication code (Auth code) issued to the authentication application in the process of authentication through the blockchain. The medication information providing apparatus stores the second authentication information in the IN area of the block, and stores the medication prescription information and the user identification information in the OUT area of the same block. Therefore, the medication information providing apparatus can easily check whether the authentication code is issued to a customer who is treated at a hospital, or at which pharmacy a prescription is given to a customer by searching the block chain using the authentication code as a kit value.

The medication information providing apparatus generates third authentication information based on the second random number value. The medication information providing apparatus may generate the second random number value as the third authentication information as it is or generate a hash value for the second random number value as the third authentication information. The third authentication information is used as an access token in the authentication agent process. The medication information providing apparatus stores the third authentication information in the IN area of the block, and stores the medication prescription information and the user identification information in the OUT area of the same block. Therefore, similar to the authentication code, the medication information providing apparatus can easily check whether the access token for the customer of a specific company is issued by searching the block chain using the access token as a kit value.

The medication information providing apparatus also generates fourth authentication information based on the medicine prescription information and the user identification information. The medication information providing apparatus may generate the hash value calculated by using the medication prescription information and the user identification information as the input of the hash function, as the fourth authentication information. The medication information providing apparatus stores the fourth authentication information in the IN area of the block and the third authentication information, that is, the access token, in the OUT area of the same block. Therefore, the medication information providing apparatus can easily check the access token issued for the corresponding customer by searching the blockchain based on the information of the specific customer of the specific affiliate.

In addition, the medication information providing apparatus may generate the fifth authentication information based on the partner identification information using the block chain and store the fifth authentication information in the block of the block chain together with the affiliate identification information.

The authentication code or access token may have a validity period. The medication information providing apparatus may determine whether a predetermined validity period of the authentication code or the access token has elapsed based on the generation time of the block in which the authentication code or the access token is stored. When receiving the authentication code or access token that has passed the validity period from the user device or the like, the medication information providing device may notify that the authentication code or the access token is invalid and may notify the user to perform the login authentication process again.

According to one disclosure, the medication information providing apparatus generates first authentication information based on user identification information for automatic authentication of at least one device, and includes the first authentication information in the IN area of a transaction and Blocks including prescription information, user identification information, and personal information consent in the OUT area of the transaction may be stored in the blockchain.

In addition, according to one disclosure, the medication information providing apparatus generates the second authentication information based on the first random number value, includes the second authentication information in the IN area of the transaction, and stores the medicine prescription information and the user identification information. The block included in the OUT area of the transaction may be stored in the blockchain, and the second authentication information may be issued as an authentication code.

In addition, according to one disclosure, the medication information providing apparatus generates the third authentication information based on the second random number value, includes the third authentication information in the IN area of the transaction, and stores the medicine prescription information and the user identification information. The block included in the OUT area of the transaction may be stored in the blockchain, and the third authentication information may be issued as an access token.

In addition, according to one disclosure, the medication information providing apparatus searches for a blockchain based on user identification information included in a patient-specific medication information request requested by at least one device, and corresponds to the first authentication information and the third authentication information. The personal information consent and access token may be checked, and if the personal information consent and access token exist, patient-specific medication information may be provided to at least one device. As described above, the step of acquiring medicine information prescribed by the user may include reading an image of at least one of a user's diagnosis, medical card, prescription, and insurance certificate, and reading an optical character reader (OCR) from the read OCR information. At least one of insurance contract information, personal characteristic information, prescription drug information, medication information, and medical treatment information may be obtained.

It is also possible to provide a computer program product comprising a computer readable storage medium comprising instructions for performing the methods provided herein.

2A is a diagram illustrating types of a user device for detecting a current state of a user, according to an exemplary embodiment.

According to an embodiment, the user may include a plurality of user devices 100. According to an embodiment, the user may further include a plurality of wearable devices 100-1, 100-2, 100-3, 100-4, and 100-5 that can measure biometric information. The user device 100 may also be one of wearable device types. The user device 100 may register the plurality of wearable devices 100-1, 100-2, 100-3, 100-4, and 100-5.

The user device 100 may directly measure the biometric information of the user. In addition, the user device 100 may obtain information on the current state of the user from the plurality of wearable devices 100-1, 100-2, 100-3, 100-4, and 100-5.

The user device 100 may detect the current state of the user and provide the medication information providing device.

2B is a diagram illustrating a wearable device that measures a current state of a user and provides state information of the user to a medication information providing device.

As shown in FIG. 2B, the wearable device 100 may include a probe 180. The probe 180 may be attached to the body of the user. According to an embodiment, the probe 180 may be attached to the body of the user in a non-contact manner. According to an embodiment, the probe 180 may be mounted in an inner skin of leather, rubber, plastic, or the like included in the wearable device 100.

The probe 180 may be installed to obtain impedance data from a portion attached to the body of the user. The probe 180 may be installed to measure a change in blood glucose concentration resulting in a change in the impedance spectrum of the dielectric in the blood.

According to an embodiment of the present disclosure, the probe 180 may measure an impedance change by using an alternating current. The probe 180 may sense an impedance change of the user's body by radiating an alternating current and sensing a change in the returned current.

According to one disclosure, the user device 100 may determine whether the user drank a lot of alcohol the day before by analyzing the change in blood alcohol concentration by detecting a change in the body impedance of the user, or the user's oxygen concentration in the blood The analysis may determine the user's fatigue, sleep state, and the like.

3 is a view for explaining an embodiment of informing the medication information to the user's device according to one disclosure.

According to one disclosure, when the user's device is a wearable watch, the wearable device may inform simple information about medicine medication on the wearable device.

For example, the notification message 2002 may be displayed on the wearable watch 100. The reminder message 2002 is a current time of taking a medicine, and may include information for eating one tablet 30 minutes after eating. In addition, the notification message 2002 may include a notice. For example, the notification message 2002 may include a content to eat at the same time as the vitamin, in order to maximize the effect of the current medication.

4 is a diagram illustrating a device screen for obtaining user information for providing medication information according to one disclosure.

According to one disclosure, a screen of a device for providing medication information may include a current prescription history, customer identification information, a bill amount, customer specifics, past prescription details, a customer notepad, a list of past prescriptions, and the like. However, it is obvious that the items displayed on the screen are exemplary and may vary depending on the AI search result.

5 is a diagram illustrating an embodiment of regenerating and providing medication information as a response to a question related to medication information is received from a user device according to one disclosure.

According to one disclosure, the medication information providing apparatus may provide a step of providing notification information according to a time when a user should take a medicine. For example, the medication information providing apparatus may provide a notification for taking a medicine once every eight hours when the medicine is a medicine to be taken three times a day or once every eight hours.

According to one disclosure, the medication information providing apparatus may provide a step of transmitting the question information to the user device after a period of time for which the user should take the medicine.

For example, the medication information providing device is a user device, whether the user has taken medicine, how many times a day he has taken the medicine, whether the medicine has been taken according to the correct dosage information, and whether there is no abnormality after taking the medicine, After taking the medicine, you may be asked whether it is effective.

According to one disclosure, when the medication information providing apparatus does not receive the answer information about the question information from the user apparatus, it may provide a step of providing an alert notification to the user apparatus.

For example, the medication information providing device may transmit a warning notification notifying the user to take the medicine when the answer to the question “Did you take the second medicine of the day ~” is not received from the user device? have. In this case, the warning notification may include at least one of a visual message, an audio notification, and a vibration notification.

According to one disclosure, the medication information providing apparatus may provide a step of detecting new effect information or new side effect information not included in the medication information of the medicine, based on the answer information.

For example, the medication information providing apparatus may query whether a side effect such as hair loss occurs after taking the medicine based on the family history of the user. In this case, when the answer is received from the user device that hair loss has occurred, it may be determined that the medicine may affect hair loss.

Alternatively, when the medication information providing apparatus receives an answer from the user device that hair loss is improved, it may be determined that a new effect of hair loss improvement occurs even if the medicine is not a drug related to hair loss.

According to one disclosure, the medication information providing apparatus may provide a step of generating additional medication information by matching the current state information of the user with new effect information or new side effect information.

For example, if the user took a medicine prescribed for a headache, and the positive effect of hair loss improvement occurred, the additional medication was matched with the user, the prescribed medicine, the current state of the user, the surrounding environment, and the like. Information can be generated. In this case, the additional medication information may include a user's characteristics and a new effect corresponding to the existing prescription medication information. The new medication information may be stored in a database or a cloud server.

According to one disclosure, the medication information providing apparatus may provide a step of transmitting additional medication information to a drug company server for manufacturing a medicine. For example, the corporate server may include a hospital server, a server of a medical institution, a server of a drug provider, a pharmaceutical company, and the like, but is not limited thereto. According to one disclosure, if the medication information providing apparatus receives a continuous request for additional medication information from the drug company server, it may provide a step of requesting additional question information related to the additional medication information to the drug company server.

For example, a server of a drug manufacturing company that manufactures a headache medicine may inform a user of a particular medicine that the effect of hair loss improvement has occurred. Pharmaceutical manufacturers can use these effects to embark on new drug development and may need more information. Accordingly, the drug manufacturing company may prepare various questions about the new effects of the existing medicines and transmit them to the medication information providing device. In this case, the medication information providing apparatus may be provided with a predetermined fee in exchange for providing a new effect / side effect, or in exchange for receiving a new question, and may provide a part of the predetermined fee to the user.

Upon receiving the additional question information from the drug company server, the method may provide a step of transmitting the additional question information to the user device.

Upon receiving the additional answer information from the user device, generating new additional medication information based on the additional answer information. According to one disclosure, as the medication information providing apparatus provides additional medication information to the drug company server, it may provide a step of receiving a compensation based on cryptocurrency from the drug company server.

In addition, according to one disclosure, the medication information providing apparatus may provide a step of providing a reward based on a cryptocurrency to an account of the user apparatus when receiving the additional answer information from the user apparatus.

In this case, the medication information providing apparatus has an advantage of providing new medication information, etc., preferentially, to a company server, a user device, or the like, which is connected to a previously signed blockchain. In addition, since the provision and receipt of such information is made in the blockchain in which privacy is maintained, the confidentiality effect can be enhanced.

According to one disclosure, to make up for the above, FIG. 9 will be described first.

9 is a flowchart illustrating a method of authenticating a user while maintaining privacy between members using a blockchain according to one disclosure.

According to one disclosure, the medication information providing apparatus 200, in order to authenticate a user, the FIDO server 500, the authentication application server 510, the authentication service interworking server 520, and the blockchain server 530. ), The main server 540 and the like. According to an embodiment, the configuration of the medication information providing apparatus 200 may be modified in various forms.

According to one disclosure, a method for obtaining information necessary for generating medication related information from a user terminal or an external device by the medication information providing apparatus 200 will be described as an example of using an insurance application. It does not limit The medication information providing apparatus 200 may execute a program for generating medication information by using a predetermined application, and does not limit the type of application. Furthermore, an extended example of authenticating a user and transmitting the obtained information to another company server (eg, an insurance company server, a pharmaceutical company server, etc.) will be described.

When the user drives the insurance application 104, a login screen 600 is displayed on the medication information providing apparatus 200. On one side of the login screen there is a button that can act as a login for the account of the authentication application (102). When the user clicks the button, the insurance application 104 transmits a login request to the authentication application 102 (S500).

The authentication application 102 performs authentication through the FIDO server 500 (S502, S504). For example, the authentication application 102 displays a fingerprint authentication request screen on the user device, receives a user's fingerprint, receives the fingerprint, and transmits the fingerprint to the FIDO server 500. If the fingerprint is a registered fingerprint, authentication is successful. Notify authentication application 102 of the result (eg, FIDO token). Although the present embodiment illustrates fingerprint authentication through the FIDO server 500 as a user authentication method, the present invention is not limited thereto and various conventional user authentication methods may be applied.

According to one disclosure, the authentication application 102 may extract feature points of a face from an image of a face of a user, and perform user authentication using the feature points of the face. The authentication application 102 transmits the feature points of the user's face to the FIDO server 500, and the FIDO server 500 determines whether the feature points of the user's face match the feature points of the registered user's face, The authentication application 102 may be informed of the success result (eg, FIDO token). If the user authentication is successful, the authentication application 102 requests the authentication code to the authentication application server 510 (S506). The authentication code request may include an authentication success result (FIDO token) received from the FIDO server 500. The authentication application server 510 verifies the FIDO token or the like included in the authentication code request through the FIDO server 500 at the request of the authentication code of the authentication application 102 (S508), and if the verification is successful, the authentication application 102. The authentication code request is transmitted to the authentication service interworking server 520 (S510).

The companion server 520 confirms whether or not to agree the personal information to the blockchain server 530 based on the identification information and the user identification information of the medication information providing apparatus (S512). The identification information and the user identification information of the medication information providing apparatus may be previously stored in the insurance application and the authentication application, or may be input by the user through the user device.

 The blockchain server 530 searches the blockchain based on the kit value generated based on the identification information and the user identification information of the medication information providing apparatus and checks whether a user's personal information provision agreement exists for the medication information providing apparatus.

For example, the consent of the personal information is stored in the blockchain along with the first authentication identification information, so that the blockchain server 530 is a kit value generated based on the identification information and the user identification information of the medication information providing apparatus 200. The IN area of each block of the blockchain can be searched to determine whether there is a personal information agreement.

The blockchain server 530 generates an authentication code and delivers it to the authentication service interworking server 520 (S514). The authentication service interworking server 520 sends the received authentication code and personal information consent to the authentication application 102. Transfer (S516). If the personal information provision agreement for the insurance application 104 does not exist, the medication information providing apparatus 200 displays a screen for the personal information provision agreement, and receives the personal information consent from the user linked server 520 It is transmitted to the blockchain server 530 via the (S518, S520). When the blockchain server 530 receives the consent of the personal information, the blockchain server 530 together with the first authentication identification information is stored in the block of the blockchain.

If there is a personal information agreement and receives an authentication code from the blockchain server 530, the authentication application 102 transmits the authentication code to the insurance application 104 (S522). The insurance application 104 requests an access token for accessing an insurance company server based on the authentication code (S524). The access token request is transmitted to the blockchain server 530 via the interworking server 520 (S526).

The blockchain server 530 generates the third authentication identification information and issues it as an access token (S528). The access token is transferred to the insurance application 104 via the interworking server 520 (S530). When the issuance of the normal access token is completed, the user device may display a login success message. The insurance application 104 may use various services such as inquiry of desired information by accessing an insurance company server using the access token after issuing it.

According to an embodiment, if the insurance application 104 installed in the medication information providing apparatus 200 first accesses the insurance company server, the insurance company server may determine whether the pharmacy membership agreement is agreed with the medication information providing apparatus 200 or the user device. 100 may be requested. Although one insurance company server is not shown in the drawings, it is apparent that the user device and the insurance company server can communicate via a network.

In addition, the medication information providing apparatus 200 may migrate data related to the medication map of the user to the insurance company server.

In another embodiment, the insurance application 104 may request and receive personal information of the user. That is, the user transmits a personal information request through the insurance application 104 (S532). The privacy request includes an access token issued by the insurance application 104.

The interlocking server 520 verifies whether the access token included in the personal information request is normally issued through the blockchain server 530, and whether there is a personal information agreement for the user who uses the medication information providing apparatus 200. Verify (S534). If the verification is successful, the companion server 520 requests and receives the personal information of the user stored in the server 540 or the medication information providing apparatus 200 (S536, S538), and delivers it to the insurance application 104. (S540). The personal information inquiry process (S532, S534, S536, S538) of the present embodiment may be omitted according to an embodiment.

According to one disclosure, the medication information providing apparatus 200 may generate and provide accurate medication information by using user identification information obtained by authenticating a user.

6 is a diagram illustrating a configuration of a medication information providing apparatus according to one disclosure.

According to one disclosure, there is provided a medication information providing apparatus 200 including a processor 1300 and a memory storing instructions executable by the processor 1300, wherein the processor 1300 according to one disclosure executes instructions by executing instructions. Extracts the user identification information and the medical identification information from the claim proof information, generates the corresponding claim information from the user identification information and the medical identification information, and outputs a request for payment of a fee corresponding to the claim information. And in response to obtaining a fee through the medication information providing apparatus, transmitting insurance claim information to the insurance company server, obtaining interests of the user based on user identification information, and storing a plurality of advertisements previously stored according to the interests of the user. Create a priority for the content, and order multiple ad content in order of priority Typically it can be exposed, and outputs the receipt through the display in accordance with the completion of the sending of the claims information.

According to an embodiment of the present disclosure, the processor 1300 checks the number of claims received at predetermined intervals, and when the number of claims is not exceeded a predetermined threshold, at least one other medication information providing device through the blockchain network. A sync mode for real-time synchronization of the consensus method with the 200 is performed, and when the number of claims is exceeded a predetermined threshold, the consensus method with the terminal 200 is executed in real time. By executing an un-sync mode, data synchronization with at least one other medication information providing apparatus 200 may be deactivated.

According to one disclosure, the processor 1300 automatically authenticates user identification information by using a blockchain in order to synchronize real time data with at least one other medication information providing apparatus 200 in a sink mode, and the processor 1300. ) Generates the first authentication information based on the identification information and the user identification information of the medication information providing apparatus for automatic authentication of the user identification information, and includes the first authentication information in the IN area of the transaction and the medication information. A block containing the identification information, the user identification information, and the personal information consent of the providing device in the OUT area of the transaction is stored in the blockchain, the second authentication information is generated based on the first random number, and the second Block a block that includes authentication information in the IN area of the transaction and includes identification information and user identification information of the medication information providing device in the OUT area of the transaction. Store in the chain, issue the second authentication information as the authentication code, generate the third authentication information based on the second random number value, include the third authentication information in the IN area of the transaction, and provide medication information Stores the block containing the identification information and the user identification information in the OUT area of the transaction in the blockchain, issues the third authentication information as an access token, and is included in the personal information request of the insurance application of the user's device. The blockchain is searched based on the identification information and the user identification information of the medication information providing apparatus to confirm whether the personal information corresponding to the first authentication information and the third authentication information is agreed and the access token, and the personal information agreement and the access token exist. If so, personal information can be provided for insurance.

Further, according to one disclosure, the processor 1300 is based on the identification information and the user identification information of the medication information providing apparatus included in the authentication code request of the insurance application of the user device, in order to issue the third authentication information to the access token. The blockchain may be searched to determine whether to agree to the personal information corresponding to the first authentication information, and if there is a consent to the personal information, the second authentication information may be transmitted to the insurance application.

According to one disclosure, the medication information providing apparatus 200 operates based on a first blockchain that uses a first cryptocurrency, and provides second medication information that operates based on a second blockchain that uses a second cryptocurrency. Communicate with device 200.

According to one disclosure, in the sink mode, the processor 1300 may claim the second insurance claim information of the user, the second insurance claim information of the user, and the first insurance claim information from the second medication information providing apparatus 200. Obtains the first transaction information requesting the sum of the information and the second transaction information requesting the sum of the first claim information to the second claim information, and the first transaction information includes the medication information providing apparatus 200 and the insurance company server. If the terms of the agreement are satisfied, the second claim information is subordinate to the validity of the second transaction information, and the second claim information is added to the first claim information, and the second claim information is added to prove the agreement condition to the first claim information. Digital signatures can be added and sent to nodes on the network of the first blockchain.

According to one disclosure, the processor 1300 calculates a first hash value by applying a hash function to the first claim information to which the second claim information is added, and the user's identification information and medication information providing apparatus 200. By encrypting the first hash value using the identification information of the second medication information providing apparatus 200 and the identification information of the second medication information providing apparatus 200, a first password representing the digital signature of the first transaction information is generated, and the second insurance claim information is added. The first cryptogram and the first insurance claim information may be transmitted to a node on the network of the first blockchain.

The receiving of the user identification information from the user may include: recognizing the face of the user, receiving face identification information of the user, receiving fingerprint information of the user, receiving ID / PW information of the user, and the user Receiving the claim claim proof of information, may include at least one of.

By one disclosure, the insurance claim proof information of the user is included in the electronic code attached to at least one of the medical certificate, medical card and prescription, the electronic code attached to the insurance certificate, the electronic code, barcode, QR code, NFC tag, image It may include at least one of the tags.

According to one disclosure, the processor 1300 may use the identification information of the user obtained from the insurance claim proof information of the user, the family history of the user, insurance information of the user, insurance information of the user's family, insurance amount of the user The control unit may determine whether the medical diagnosis contents of the user may be covered by the insurance of the user, and control to display whether the medical diagnosis contents of the user are covered by the insurance.

According to one disclosure, the processor 1300 receives a user input for selecting an advertisement service provided to a user, transmits information related to the selected advertisement service to a user's device, and provides a service related to an advertisement service. The identification information of the user can be transmitted.

According to one disclosure, the processor 1300 acquires a second learning model based on a result of learning a user's interest related to insurance coverage information and medication information using a current learning model, Recurrent Neural Network (RNN). The advertisement text to be provided to the user may be determined using the second learning model.

7 is a block diagram illustrating a detailed configuration of an apparatus for providing medication information according to one disclosure.

As illustrated in FIG. 7, the medication information providing apparatus 200 according to an embodiment may include a controller 1300, a communication unit 1500, and a memory 1700. However, not all components illustrated in FIG. 7 are essential components of the medication information providing apparatus 200. The medication information providing apparatus 200 may be implemented by more components than those illustrated in FIG. 7, or the medication information providing apparatus 200 may be implemented by fewer components than the components illustrated in FIG. 7. have.

For example, as illustrated in FIG. 7, the medication information providing apparatus 200 according to an embodiment may include a user input unit 1100 and an output unit in addition to the controller 1300, the communication unit 1500, and the memory 1700. The processor 1200 may further include a sensing unit 1400, and an A / V input unit 1600.

For example, the medication information providing apparatus 200 according to an embodiment may be a board for medication information providing apparatus including the controller 1300, the communicator 1500, and the memory 1700, and according to one embodiment, the medication information The providing apparatus 200 may include at least one of a user input unit 1100, an output unit 1200, a sensing unit 1400, and an A / V input unit 1600 in addition to the control unit 1300, the communication unit 1500, and the memory 1700. It may be a medication information providing apparatus further comprising one.

The user input unit 1100 means a means for a user to input data for controlling the medication information providing apparatus 200. For example, the user input unit 1100 includes a key pad, a dome switch, a touch pad (contact capacitive type, pressure resistive layer type, infrared sensing type, surface ultrasonic conduction type, and integral type). Tension measurement method, piezo effect method, etc.), a jog wheel, a jog switch, and the like, but are not limited thereto.

The user input unit 1100 may receive a user input for user input for controlling an operation of a module installed in the medication information providing apparatus.

The output unit 1200 may output an audio signal, a video signal, or a vibration signal, and the output unit 1200 may include a display unit 1210, an audio output unit 1220, and a vibration motor 1230. have. In an embodiment, the output unit 1200 may output a notification message in the form of audio, video, and / or vibration.

The display unit 1210 displays and outputs information processed by the medication information providing apparatus 200.

The sound output unit 1220 outputs audio data received from the communication unit 1500 or stored in the memory 1700. In addition, the sound output unit 1220 outputs a sound signal related to a function (for example, a call signal reception sound, a message reception sound, and a notification sound) performed by the medication information providing device 200. For example, the sound output unit 1220 may output an alarm sound for notifying that an event has occurred.

The controller 1300 generally controls the overall operation of the medication information providing apparatus 200. For example, the controller 1300 executes programs stored in the memory 1700, such that the user input unit 1100, the output unit 1200, the sensing unit 1400, the communication unit 1500, and the A / V input unit 1600 are provided. ) Can be controlled overall. In addition, the controller 1300 may perform a function of the medication information providing apparatus 200 by executing programs stored in the memory 1700. The controller 1300 may include at least one processor. The controller 1300 may include a plurality of processors or one processor in an integrated form according to its function and role. According to an embodiment, the controller 1300 may include at least one processor configured to provide a notification message by executing at least one program stored in the memory 1700.

The sensing unit 1400 may detect a state of the medication information providing apparatus 200, a state of a user, or a state around the medication information providing apparatus 200, and transmit the detected information to the controller 1300.

The sensing unit 1400 includes a geomagnetic sensor 1410, an acceleration sensor 1420, a temperature / humidity sensor 1430, an infrared sensor 1440, a gyroscope sensor 1450, and a position sensor. (Eg, GPS) 1460, barometric pressure sensor 1470, proximity sensor 1480, and RGB sensor (RGB sensor) 1490, but are not limited thereto. Functions of the respective sensors can be intuitively deduced by those skilled in the art from the names, and thus detailed descriptions thereof will be omitted.

The communicator 1500 may include one or more components that allow the medication information providing apparatus 200 to communicate with another medication information providing apparatus (not shown) and the server 2000. For example, the communicator 1500 may include a short range communicator 1510, a mobile communicator 1520, and a broadcast receiver 1530. Another medication information providing device (not shown) may be a computing device or a sensing device, but is not limited thereto. For example, the other medication information providing apparatus may be a medication information providing apparatus installed in another pharmacy that synchronizes the medication information providing apparatus 200 with a blockchain in real time or non-real time.

The short-range wireless communication unit (15500) 1510 includes a Bluetooth communication unit (500), a Bluetooth Low Energy (BLE) communication unit (500), a near field communication unit (500) (Near Field Communication unit), and a WLAN ( Wi-Fi communication unit 1500, Zigbee communication unit 1500, infrared data association (IrDA) communication unit 1500, WFD (Wi-Fi Direct) communication unit 1500, UWB (ultra wideband) communication unit 1500 , Ant + communication unit 1500, and the like, but is not limited thereto.

The mobile communication units 1500 and 1520 transmit and receive wireless signals with at least one of a base station, an external device, and a server on a mobile communication network. Here, the wireless signal may include various types of data according to transmission and reception of a voice call signal, a video call call signal, or a text / multimedia message.

The broadcast receiving unit 1530 receives a broadcast signal and / or broadcast related information from the outside through a broadcast channel. The broadcast channel may include a satellite channel and a terrestrial channel. According to an embodiment, the medication information providing apparatus 200 may not include the broadcast receiving unit 1530.

In an embodiment, the communication unit 1500 may receive a video sequence including a plurality of frames from a camera installed in the medication information providing apparatus. According to an embodiment of the present disclosure, the communication unit 1500 may transmit a command for controlling an operation of a module installed in the medication information providing apparatus to a module installed in the medication information providing apparatus.

The A / V input unit 1600 is for inputting an audio signal or a video signal, and may include a camera 1610 and a microphone 1620. The camera 1610 may obtain an image frame such as a still image or a moving image through an image sensor in a video call mode or a photographing mode. The image captured by the image sensor may be processed by the controller 1300 or an additional image processor (not shown). For example, an image captured by the camera 1610 may be used as information for determining whether an event has occurred.

The microphone 1620 receives an external sound signal and processes the external sound signal into electrical voice data. For example, the microphone 1620 may receive a sound signal from an external medication information providing apparatus or a user. The microphone 1620 may use various noise removing algorithms for removing noise generated in the process of receiving an external sound signal.

The memory 1700 may store a program for processing and controlling the controller 1300, and may store data input to the medication information providing apparatus 200 or output from the medication information providing apparatus 200.

The memory 1700 may be a flash memory 1700 type, a hard disk type, a multimedia card micro type, a card type memory 1700 (e.g., SD or XD memory (1700), etc.), random access memory (RAM), static random access memory (SRAM), read-only memory (ROM), electrically erasable programmable read-only memory (EEPROM), programmable read-ROM (PROM) Only memory), magnetic memory 1700, magnetic disk, optical disk may include at least one type of storage medium.

Programs stored in the memory 1700 may be classified into a plurality of modules according to their functions. Here, the plurality of modules refers to a module that is functionally operated as software rather than hardware. For example, a UI module ( 1710, the touch screen module 1720, the notification module 1730, and the like.

The UI module 1710 may provide a specialized UI, GUI, and the like that are linked to the medication information providing apparatus 200 for each application. The touch screen module 1720 may detect a touch gesture on the user's touch screen and transmit information about the touch gesture to the controller 1300. The touch screen module 1720 according to an embodiment may recognize and analyze a touch code. The touch screen module 1720 may be configured as separate hardware including a controller.

The notification module 1730 may generate a signal for notifying occurrence of an event. The notification module 1730 may output the notification signal in the form of a video signal through the display unit 1210, may output the notification signal in the form of an audio signal through the sound output unit 1220, and the vibration motor 1230. The notification signal may be output in the form of a vibration signal.

8 is an exemplary diagram of an I-Shape Extended Curvature Gabor Classifier Bunch group.

As shown in FIG. 8A, one eye (I) -type extended Gabor filter group has 12 curved Gabor filters G = with 3 Gaussian widths (σ) and 4 curvatures (c). {g (σ1, c1), g (σ2, c2), g (σ3, c3), g (σ4, c4), g (σ5, c5), ..., g (σ12, c12)}.

In one I-type extended Gabor filter group, the curvature has four values of c = {0.0, 0.05, 0.1, 0.2} and the Gaussian width is one of σ = {0.5π, π, 2π} has a value of σ = {π}.

Thus, the 12 curved Gabor filters have eight directionality when the curvature is c = {0.0} (that is, a straight line), and μ = {when the curvature is greater than c = {0.0} (that is, a curve). 0, 1, 2, ..., 15}.

This eye-shaped extended curved Gabor filter group arranges 12 curved Gabor filters along a row with respect to curvature c and rows with a Gaussian width σ. Arranged accordingly and filtered using four curved Gabor filters of the "I" type.

These four " I " curved Gabor filters are four curved Gabor filters with a curvature of c = {0, 0.05, 0.1, 0.2} when Gaussian width is σ = {π}.

As a result, while achieving a certain level of face recognition rate, the amount of computation can be significantly reduced, the speed can be improved, and the dispersion is less than that of using all 12 curved Gabor filters. Thus, more stable face recognition performance can be obtained. have.

This grouping of features of the curved Gabor filter facilitates the extension of the curved Gabor filter by reducing the dimension of the input values for subsequent Linear Discriminant Analysis (LDA) operations.

For example, by increasing the number of curved gabor filters to be used by varying the Gaussian width and curvature, even if the number of features in the face image is increased, grouping the features and lowering the dimension of the input value reduces the burden of learning LDA. You can. It is also useful for improving LDA learning.

The medication information providing apparatus 200 performs a linear discriminant analysis (LDA) operation using an I-type extended curve Gabor filter group as an input value.

Here, the medication information providing apparatus 200 performs an LDA operation independently for each eye (I) -type extended curve Gabor filter group.

To this end, the medication information providing apparatus 200 may include a plurality of linear discriminant analysis units (not shown), and LDA operation for one eye (I) -type extended curve Gabor filter group for each linear discriminant analysis unit. Do this.

Accordingly, the medication information providing apparatus 200 outputs a plurality of linear discrimination analysis results (ie, basis vectors) for one sub-image, and generates an observation node based on the output of the plurality of linear discrimination analysis results. And outputs the generated observation node.

The medication information providing apparatus 200 projects the features (ie, feature vectors) of the eye (I) -type extended curve Gabor filter group for each sub-image to the basis vector. At this time, the projected vector becomes an observation node.

The medication information providing apparatus 200 according to the present embodiment generates approximately 2400 features for one sub image.

Here, generating approximately 2400 features is more than twice as long as outputting approximately 1400 features, and performs better than outputting 1400 features and has less variance, resulting in a relatively stable face. Because it can be recognized. This was obtained by experiment.

11 is a view for explaining a technical feature of sharing medication information using a blockchain network according to one disclosure.

According to one disclosure, the medication information providing apparatus 200 may obtain identification information, medication information, medication prescription information, medical behavior information, etc. of the user from a prescription of the user.

The medication information providing apparatus 200 may apply a blockchain to block the forgery of the medication information of the user and the biometric / body information of the user. For example, the medication information providing apparatus may block a user's information (for example, a parameter value used for prediction, an effect and side effects of medication, etc.) using a random value and a biosignal value set by the user as encryption keys. Can be stored in a chain.

In this case, the random value may be 12 or more digits, and is a value managed by the central server, and the biosignal value may be obtained by using a function of a wallet included in a management app, that is, a medication information providing apparatus. For example, the biosignal value may include fingerprint recognition, facial recognition, iris recognition, and the like.

In addition, when patient information is propagated to a node of a pharmacy in block form, encryption is automatically applied, so it is difficult for the pharmacy to directly refer to this. In this case, the pharmaceutical company may acquire the individual key of the patient by paying a predetermined fee to the central server to refer to the patient's information.

12 is a view for explaining an embodiment related to non-contact sensing according to one disclosure.

For example, a method of sensing a user's state when the user is driving will be described. The device for sensing the state of the user may be separately mounted to the moving means of the user or may be included in the moving means. This is not restrictive.

The sensing device may sense a state of a driving user in real time. For example, information related to the user's biometric information may be sensed such as a user's heartbeat, the number of breaths, the proportion of air in the breath, the user's voice status, and the user's posture.

In this case, the sensing device may transmit sensing information about the user's state to the medication information providing device. In addition, the sensing device may diagnose the user's condition by using the sensing information of the user's condition. For example, the sensing device measures a numerical value of the user's heart rate or respiratory activity to be outside the range of the average value. In this case, it may be determined that the fatigue of the user is increased. In this case, the sensing device may transmit information indicating that the fatigue of the user has increased to the medication information providing device.

The sensing device may be comprised of a high speed radar chip, at least one biosensor or environmental sensors. The function of each sensor can be intuitively deduced by those skilled in the art from the name, and does not limit the type and function of the sensor.

In addition, as described above, when the pharmacist wants to view the patient's information by using the individual key of the patient, the information reference request may be transmitted to the patient, where the patient who receives the information reference request grants the information reference. You can send an answer. In this process, the patient may be paid a small fee. In this case, the fee may be received through the blockchain. Some embodiments may also be implemented in the form of a recording medium containing instructions executable by a computer, such as a program module executed by the computer. Computer readable media can be any available media that can be accessed by a computer and includes both volatile and nonvolatile media, removable and non-removable media. In addition, the computer readable medium may include a computer storage medium. Computer storage media includes both volatile and nonvolatile, removable and non-removable media implemented in any method or technology for storage of information such as computer readable instructions, data structures, program modules or other data.

Further, in this specification, “unit” may be a hardware component such as a processor or a circuit, and / or a software component executed by a hardware component such as a processor.

The foregoing description of the present invention is intended for illustration, and it will be understood by those skilled in the art that the present invention may be easily modified in other specific forms without changing the technical spirit or essential features of the present invention. will be. Therefore, it should be understood that the embodiments described above are exemplary in all respects and not restrictive. For example, each component described as a single type may be implemented in a distributed manner, and similarly, components described as distributed may be implemented in a combined form.

The scope of the present invention is shown by the following claims rather than the above description, and all changes or modifications derived from the meaning and scope of the claims and their equivalents should be construed as being included in the scope of the present invention. do.

Claims (12)

Acquiring medication history information of the user from a server using identification information of the user;
Obtaining medicine information prescribed by the user from a medicine prescription related document provided by the user;
Obtaining current state information such as body temperature of the user, heart rate, blood pressure of the user, and blood sugar information from a user terminal;
By using the AI first learning model, based on one or more of the user's medication history information, the medicine information and the current status information of the user, the medication information, precautions, side effects, medicines suitable for the current status of the user Generating first customized medication information including at least one of a proper intake number and a proper intake time of the medicine;
Providing the user with customized medication information to the user terminal;
Generating question information related to the user-specific medication information by using an artificial intelligence second learning model, and providing the generated question information to the user terminal;
Receiving answer information on the question information from the user terminal; and
And modifying the first user-specific medication information based on the answer information to provide second user-specific medication information according to the state of the user who is taking the medication. The method of claim 1,
Acquiring surrounding environment information including temperature, humidity, fine dust concentration, and weather information around the current user's location from the user terminal or server;
Modifying the first user-specific medication information to maximize the effect of the user's medicine intake based on the surrounding environment information; and
And providing the modified first user-specific medication information to the user terminal. The method of claim 1,
On the result of learning the medical identification information, disease name information, diagnosis name information, medical history information, medical treatment history information, information on the prescribed medicines, medicine medication information corresponding to the medical identification information related to the medicine information prescribed by the user Acquiring an artificial intelligence first learning model based on the artificial intelligence first learning model and generating medicine medication information to be provided to the user using the obtained artificial intelligence first learning model;
The first learning model is current state information of the user. By setting a weight on at least one of the genetic characteristic information and the surrounding environment information of the user, the time-based medication medication information according to the current state information of the user, characterized in that the patient-specific medication information providing method. The method of claim 1,
Obtaining health state information including at least one of a user's psychological state, drinking state, pain status, meal information, allergy information, family history information, and sleep state information from the user terminal;
Generating question information related to the user-specific medication information by using the artificial intelligence second learning model that learns medication information suitable for a situation by using the health state information; And
And regenerating the user-customized medication information based on the response information periodically obtained from the user terminal. The method of claim 1,
Providing the user-specific medication information to the user terminal,
Providing notification information according to a time at which the user should take the medicine;
Transmitting the question information to the user terminal after a predetermined period of time for which the user should take the medicine; and
If it does not receive the answer information for the question information from the user terminal, providing a warning notification to the user terminal; comprising, patient-specific medication information providing method. The method of claim 1,
Detecting new effect information or new side effect information not included in the medication information of the medicine based on the answer information; and
Generating additional medication information by matching the current status information of the user with new effect information or new side effect information;
And transmitting the additional medication information to a pharmaceutical company server that manufactures the pharmaceutical product. The method of claim 6,
When receiving the continuous request for the additional medication information from the drug company server, requesting additional question information related to the additional medication information to the drug company server;
Transmitting the additional question information to the user terminal in response to receiving the additional question information from the drug company server;
And generating new additional medication information based on the additional answer information when receiving the additional answer information from the user terminal. The method of claim 7, wherein
Receiving a remuneration based on cryptocurrency from the drug company server in response to providing the additional medication information to the drug company server; And
And receiving the additional answer information from the user terminal, providing a reward based on cryptocurrency to the account of the user terminal. The method of claim 1,
Encrypting the first customized medication information and the second customized medication information using a blockchain; and
And storing the encrypted first user-specific medication information and the second user-specific medication information to be provided to at least one terminal authenticated through the blockchain. The method of claim 9,
For the automatic authentication of the at least one terminal, generating first authentication information based on user identification information, including the first authentication information in the IN area of the transaction, drug prescription information, user identification information and individual In the blockchain, a block is included in the OUT area of the transaction.
A block for generating second authentication information based on a first random number value, including the second authentication information in an IN area of a transaction, and including drug prescription information and user identification information in an OUT area of a transaction; Store in the blockchain, issue the second authentication information as an authentication code,
A block for generating third authentication information based on a second random value, including the third authentication information in an IN area of a transaction, and including drug prescription information and user identification information in an OUT area of a transaction; Store in the blockchain, issue the third authentication information as an access token,
The blockchain is searched based on the user identification information included in the patient-specific medication information request requested by the at least one terminal to confirm whether the personal information corresponding to the first authentication information and the third authentication information is agreed and the access token, And providing the patient-specific medication information to the at least one terminal if the personal information consent and the access token exist. The method of claim 1,
Acquiring the drug information prescribed by the user,
Read an optical character reader (OCR) image of at least one of the user's medical certificate, medical card, prescription, and insurance policy, and from the read OCR information, the insurance contract information, personal characteristics information, prescription medicine information, and medication. And at least one of information and medical care information. A computer program product comprising a computer readable storage medium, the storage medium comprising instructions for performing the method of claim 1.

Images